hLife is a peer-reviewed english-language open-access journal published by Elsevier in Netherlands, operating under an open-access model since 2023. The journal covers Medicine.
Authors are required to pay an article processing charge to publish in hLife; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY-NC-ND license (see other journals using this license).
To date, hLife has published 193 articles. Articles are minted with DOIs through the prefix 10.1016. All submissions undergo plagiarism screening before peer review.
Keywords
pathogen biology, immunology, vaccines, structural biology, translational medicine, drugs
At a glance
- Publisher
- Elsevier
- Country
- Netherlands
- Primary language
- English
- License
- CC BY-NC-ND
- Peer review
- Anonymous peer review
- OA since
- 2023
- Review time
- 28 weeks
- DOI prefix
10.1016- Plagiarism check
- Yes
ISSN
- electronic
- 2949-9283
Frequently asked questions
Is hLife peer-reviewed?
Yes — hLife operates a Anonymous peer review review process.
Does hLife charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does hLife publish?
hLife publishes research in Medicine.
What languages does hLife accept?
hLife accepts manuscripts in English.
What is the ISSN of hLife?
ISSN:
2949-9283 (electronic).How do I submit a manuscript to hLife?
Submit through the journal's official portal: visit submission page →
How long does peer review take at hLife?
Average time from submission to publication is approximately 28 weeks.